» Articles » PMID: 38472395

Long-chain Acyl-CoA Synthetase 4-mediated Mitochondrial Fatty Acid Metabolism and Dendritic Cell Antigen Presentation

Overview
Journal Inflamm Res
Date 2024 Mar 13
PMID 38472395
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to investigate the role of Acyl-CoA synthetase 4 (ACSL4) in mediating mitochondrial fatty acid metabolism and dendritic cell (DC) antigen presentation in the immune response associated with asthma.

Methods: RNA sequencing was employed to identify key genes associated with mitochondrial function and fatty acid metabolism in DCs. ELISA was employed to assess the levels of fatty acid metabolism in DCs. Mitochondrial morphology was evaluated using laser confocal microscopy, structured illumination microscopy, and transmission electron microscopy. Flow cytometry and immunofluorescence were utilized to detect changes in mitochondrial superoxide generation in DCs, followed by immunofluorescence co-localization analysis of ACSL4 and the mitochondrial marker protein COXIV. Subsequently, pathological changes and immune responses in mouse lung tissue were observed. ELISA was conducted to measure the levels of fatty acid metabolism in lung tissue DCs. qRT-PCR and western blotting were employed to respectively assess the expression levels of mitochondrial-associated genes (ATP5F1A, VDAC1, COXIV, TFAM, iNOS) and proteins (ATP5F1A, VDAC1, COXIV, TOMM20, iNOS) in lung tissue DCs. Flow cytometry was utilized to analyze changes in the expression of surface antigens presented by DCs in lung tissue, specifically the MHCII molecule and the co-stimulatory molecules CD80/86.

Results: The sequencing results reveal that ACSL4 is a crucial gene regulating mitochondrial function and fatty acid metabolism in DCs. Inhibiting ACSL4 reduces the levels of fatty acid oxidases in DCs, increases arachidonic acid levels, and decreases A-CoA synthesis. Simultaneously, ACSL4 inhibition leads to an increase in mitochondrial superoxide production (MitoSOX) in DCs, causing mitochondrial rupture, vacuolization, and sparse mitochondrial cristae. In mice, ACSL4 inhibition exacerbates pulmonary pathological changes and immune responses, reducing the fatty acid metabolism levels within lung tissue DCs and the expression of mitochondria-associated genes and proteins. This inhibition induces an increase in the expression of MHCII antigen presentation molecules and co-stimulatory molecules CD80/86 in DCs.

Conclusions: The research findings indicate that ACSL4-mediated mitochondrial fatty acid metabolism and dendritic cell antigen presentation play a crucial regulatory role in the immune response of asthma. This discovery holds promise for enhancing our understanding of the mechanisms underlying asthma pathogenesis and potentially identifying novel targets for its prevention and treatment.

References
1.
Shipp C, Gergen P, Gern J, Matsui E, Guilbert T . Asthma Management in Children. J Allergy Clin Immunol Pract. 2022; 11(1):9-18. DOI: 10.1016/j.jaip.2022.10.031. View

2.
Pijnenburg M, Nantanda R . Rising and falling prevalence of asthma symptoms. Lancet. 2021; 398(10311):1542-1543. DOI: 10.1016/S0140-6736(21)01823-7. View

3.
Asher M, Rutter C, Bissell K, Chiang C, El Sony A, Ellwood E . Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021; 398(10311):1569-1580. PMC: 8573635. DOI: 10.1016/S0140-6736(21)01450-1. View

4.
Lajiness J, Cook-Mills J . Catching Our Breath: Updates on the Role of Dendritic Cell Subsets in Asthma. Adv Biol (Weinh). 2023; 7(6):e2200296. PMC: 10293089. DOI: 10.1002/adbi.202200296. View

5.
Haczku A . The dendritic cell niche in chronic obstructive pulmonary disease. Respir Res. 2012; 13:80. PMC: 3507810. DOI: 10.1186/1465-9921-13-80. View